DNA methylation profiling in the thalamus and hippocampus of postnatal malnourished mice, including effects related to long-term potentiation

  • Xiaoling Weng1Email author,

    Affiliated with

    • Daizhan Zhou2Email author,

      Affiliated with

      • Fatao Liu3Email author,

        Affiliated with

        • Hong Zhang1,

          Affiliated with

          • Junyi Ye1,

            Affiliated with

            • Zhou Zhang2,

              Affiliated with

              • Di Zhang2,

                Affiliated with

                • Yinan Wang2,

                  Affiliated with

                  • Liming Tao3,

                    Affiliated with

                    • Lan Cao1,

                      Affiliated with

                      • Mengyuan Kan3,

                        Affiliated with

                        • Ting Wang3,

                          Affiliated with

                          • Guoyin Feng2, 3,

                            Affiliated with

                            • Xiaolan Qin2,

                              Affiliated with

                              • Jihui Sun4,

                                Affiliated with

                                • Lin He1, 2, 3, 6Email author and

                                  Affiliated with

                                  • Yun Liu1, 5Email author

                                    Affiliated with

                                    BMC Neuroscience201415:31

                                    DOI: 10.1186/1471-2202-15-31

                                    Received: 13 June 2013

                                    Accepted: 11 February 2014

                                    Published: 20 February 2014



                                    DNA methylation has been viewed as the most highly characterized epigenetic mark for genome regulation and development. Postnatal brains appear to exhibit stimulus-induced methylation changes because of factors such as environment, lifestyle, and diet (nutrition). The purpose of this study was to examine how extensively the brain DNA methylome is regulated by nutrition in early life.


                                    By quantifying the total amount of 5-methylcytosine (5mC) in the thalamus and the hippocampus of postnatal malnourished mice and normal mice, we found the two regions showed differences in global DNA methylation status. The methylation level in the thalamus was much higher than that in the hippocampus. Then, we used a next-generation sequencing (NGS)-based method (MSCC) to detect the whole genome methylation of the two regions in malnourished mice and normal mice. Notably, we found that in the thalamus, 500 discriminable variations existed and that approximately 60% were related to neuronal development or psychiatric diseases. Pathway analyses of the corresponding genes highlighted changes for 9 genes related to long-term potentiation (5.3-fold enrichment, P = 0.033).


                                    Our findings may help to indicate the genome-wide DNA methylation status of different brain regions and the effects of malnutrition on brain DNA methylation. The results also indicate that postnatal malnutrition may increase the risk of psychiatric disorders.


                                    Malnutrition Thalamus Hippocampus Mouse model Global DNA methylation status Whole genome methylation sequencing Long-term potentiation Psychiatric disorders


                                    Nutrition represents one of the major important variables that play crucial roles in the maturation and functional development of the central nervous system (CNS) [1]. Malnutrition exerts its effects during the brain growth spurt period, and it results in a variety of brain dysfunctions [2]. Growth deficits due to malnutrition in childhood increase the incidence of infectious diseases and lead to alterations in CNS function, which have been shown to delay psychomotor development [3]. Thus, understanding the pathological effects of malnutrition will provide critical insights into the neurodevelopmental process.

                                    DNA methylation is among the best studied epigenetic modifications and is essential to mammalian development [4]. Specifically, the methylation of cytosine at CpG dinucleotides is an important regulatory modification of the genome [5]. Many epigenetic studies on DNA methylation have revealed that malnutrition during the perinatal period is highly correlated with abnormal neurodevelopment [6].

                                    Studies of epigenetic modifications benefit substantially from improved next-generation sequencing methods, and recent technologies make it possible for accurate and large-scale CpG methylation profiling [7]. Methyl-sensitive cut counting (MSCC) is a NGS method used to profile the whole DNA methylome. The MSCC genome-scale analysis is based on the concept that locations of CCGGs largely reflect the distributions of all CpGs in the mouse genome [8].

                                    In our study, we utilized a mouse model of male mice to avoid sex differences, as sexual dimorphism and sexual differentiation have been thought to underlie the sexual development of the brain and other organs, which could impact lifelong functions [9]. First, we detected the global DNA methylation status in the thalamus and the hippocampus of postnatal malnourished mice and normal mice. Because the two regions showed differences in global DNA methylation status, we employed MSCC to investigate DNA methylation to determine how extensively the two brain DNA methylomes were regulated by nutrition in early life.


                                    Mouse husbandry

                                    All animal care and use procedures were in accordance with the guidelines of the Institutional Animal Care and Use Committee for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. The parental mice in this study were purchased from Shanghai Laboratory Animal Co. Ltd. (SLAC, Shanghai, China) and housed under controlled conditions of 12 h light/12 h dark cycle at 23 ± 2°C and 35 ± 5% humidity. The parental mice had been raised for at least two generations on a control diet to attempt to minimize any trans-generational effects. The male offspring mice were weaned from the mothers at 20 days of age and were divided randomly into two groups (n = 7 in control group, n = 5 in famine group): the control group was given a standard diet (D12450B), and the famine group was fed with half of a low-protein diet (D06022301) [10]. After 6 weeks of artificial feeding, offspring mice were euthanized (the weights of the offspring mice were measured every week from weaning); the entire thalamus and hippocampus were dissected out and immediately stored at -80°C.

                                    DNA preparation

                                    Genomic DNA was isolated from ≥25 mg samples (thalamus and hippocampus of malnourished mice and normal mice) using the QIAamp DNA Mini Kit following the standard protocol (QIAGEN, Hilden, Germany). To ensure the sample quality, a Thermo NanoDrop 2000 (Thermo, Wilmington, USA) was used to detect 260/280 nm UV absorbance ratios, and concentrations were determined with a Qubit 2.0 fluorometer (Life Technologies, Carlsbad, CA). DNA length was determined by an Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA) to ensure the integrity. We constructed two MSCC libraries for each of our two brain tissues that contained pooled DNA from the control group and the famine group. Pooled DNA was used to increase the sample concentration and diminish micro-dissection variations.

                                    Global DNA methylation status detection and calculation

                                    The MethylFlash™ Methylated DNA Quantification Kit (Fluorometric) was used to detect the total amount of 5mC in the thalamus and hippocampus according to the manufacturer’s instructions (Epigentek, Farmingdale, NY). Relative fluorescence units (RFU) at 530EX/590EMnm were measured using a SpectraMax M5 (Molecular Devices, CA, USA) to calculate the global methylation status.

                                    MSCC library construction

                                    To detect cytosine methylation, MSCC utilized the restriction enzymes HpaII and MspI, which preferentially cut DNA based on its methylation status. Although both enzymes recognized the same restriction site CCGG, HpaII was a methylation-sensitive enzyme, while MspI was insensitive to methylation sites. Adaptors A and B were also created for MSCC and were synthesized by Sangon Biotech (Shanghai, China). Adaptor A contained a 5′ MmeI recognition site and a 5′ CG overhang, while adaptor B had a 3′ NN overhang. Both adapters also contained end sequences required for Illumina library construction. Then, we constructed a HpaII library and an Inverse library for our study. To correct the error during the experiment of the HpaII library and the Inverse library, we combined standard DNA in the two libraries that contained the same known methylated or no methylated sequences. Further details are provided in the Additional file 1: Supplementary Method.

                                    Library sequencing and mapping

                                    Before sequencing, we used a Perl script to extract 20 bp upstream and 20 bp downstream of every CCGG site from the whole mouse genome (mm9). Based on the UCSC Refseq database, we added annotation to these short sequences and established a CCGG sequence database. The two libraries were sequenced on the Hiseq2000 depth sequencing system (Illumina, San Diego, California). After sequencing, the HpaII library and the Inverse library data from the Hiseq2000 depth sequencing system (bcl document) were transformed into a fastq file using CASAVA software. The fastq file data were mapped to the CCGG sequence database that we constructed using MOM software. We then analyzed the number of reads in the same CCGG position to calculate the degree of methylation of each site. Standard DNA in each library was used to normalize the counts before estimating the methylation level, according to the method in Guo et al. [8].

                                    Statistical analysis

                                    Student’s t-tests were used to determine the differences in mouse weights and thalamus and hippocampus methylation levels between the control group and the famine group. For the MSCC data, we constructed a 200-bp non-overlapping windows profiling of the whole genome. Windows that involved more than 3 CpG sites sequenced were used for the subsequent analysis. For each of the 200-bp windows, we conducted Fisher exact tests to find different methylated regions (DMRs) with statistical significance (P < 0.05) and different levels of methylation changes (∆MSCC, either increase or decrease) >25%. A P value < 0.05 was considered significant in these analyses.

                                    Pathway classification and enrichment analysis

                                    Pathway analyses were performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID, http://​david.​abcc.​ncifcrf.​gov/​) [11]. Pathway classification within DAVID used the Kyoto Encyclopedia of Genes and Genomes database (KEGG, http://​www.​genome.​jp/​kegg/​pathway.​html) and PANTHER ( http://​www.​pantherdb.​org/​pathway/​). Enrichment statistics were adjusted by Benjamini correction.



                                    The weights of the offspring male mice are shown in Table  1. Data are presented as the mean ± standard deviation (SD). As determined using Student’s t-test, the famine group weighed less and the weights were significantly different from the control group (p < 0.05). During feeding, the famine group displayed the phenomena of mania and hyperactivity.
                                    Table 1

                                    Mouse weights from the beginning of artificial feeding


                                    Weight (g)/week










                                    8.69 ± 0.32

                                    19.06 ± 0.85

                                    21.57 ± 1.21

                                    23.29 ± 1.08

                                    24.53 ± 1.57

                                    25.51 ± 2.02

                                    26.04 ± 1.87


                                    8.69 ± 0.27

                                    8.82 ± 0.77

                                    10.28 ± 0.44

                                    12.46 ± 0.50

                                    13.32 ± 0.68

                                    13.02 ± 0.94

                                    11.45 ± 0.78

                                    *P < 0.05, compared with the control group.

                                    Total 5mc amount in the thalamus and hippocampus

                                    The global DNA methylation status in the thalamus and the hippocampus of postnatal malnourished mice and normal mice is shown in Figure  1. The global DNA methylation status in the thalamus was significantly higher than that of the hippocampus. In both the thalamus and the hippocampus, the control group had a higher total 5mc amount than the famine group.
                                    Figure 1

                                    The global DNA methylation levels in the thalamus and hippocampus of postnatal malnourished mice and normal mice. Data are the mean ± s.e.m. *P = 0.046 (control group and famine group in the hippocampus, Student’s t-test). **P = 6.413e-05 (control group in the thalamus and hippocampus, Student’s t-test); 4.394e-04 (famine group in the thalamus and hippocampus, Student’s t-test).

                                    DNA methylome in the thalamus and hippocampus

                                    The reads obtained from our libraries after MSCC whole genome methylation sequencing are shown in Table  2. After excluding MSCC sites with low sequencing depth, we obtained the DNA methylation profile of the thalamus (Additional file 2: Table S1) and the hippocampus (Additional file 3: Table S2). The overall methylation levels of all CCGG sites in the two tissues are shown in Figure  2. The CCGG methylation level of the hippocampus was also lower than that of the thalamus as the global DNA methylation status. The methylation differences between the famine and control groups or the thalamus and hippocampus were statistically significant (P < 0.001).
                                    Table 2

                                    MSCC Illumina sequencing statistics of the thalamus and hippocampus

                                    Library name

                                    Number of reads with appropriate adaptors

                                    Number of mapped reads (percentage)

                                    Number of CCGG sites seen at least once

                                    Average number of reads per CCGG site




                                    31413443 (80.0)






                                    20466887 (57.2)






                                    46262199 (80.6)






                                    27799576 (59.8)






                                    24301025 (81.2)






                                    15892801 (59.8)






                                    30429853 (81.0)






                                    25510407 (60.1)



                                    Figure 2

                                    The overall methylation levels of all CCGG sites in the thalamus and hippocampus (control group in gray and famine group in white). The total methylation level at CCGG sites of the hippocampus was lower than that of the thalamus. ***P < 0.001 (control group and famine group in the thalamus and hippocampus, control group in the thalamus and hippocampus, famine group in the thalamus and hippocampus, Student’s t-test).

                                    In addition, we also showed the methylation level in internal, shore and external CGIs of the thalamus and the hippocampus (Additional file 1: Figure S1a and S1b). In the two groups of both tissues, the level of methylation in the internal of the CpG islands was lower than that of the external of the CpG islands. Furthermore, the famine group had a lower methylation level than the control group at the external of the CpG islands, whereas it was hypermethylated in the internal of the CpG islands in both brain regions. The whole genome methylation pattern showed that the methylation level near the transcription initiation site (TSS) was lower than any other position (Additional file 1: Figure S2).

                                    We combined the mouse thalamus gene expression data from the NCBI GEO database (GDS1490) with our MSCC thalamus data for the control group. First, we divided the database expression genes into three parts: high-expression genes, moderate-expression genes, and low-expression genes. Then, the MSCC data were integrated to the three parts of the expression genes. The relationship between the methylation level and gene expression is shown in Additional file 1: Figure S3a and S3b. The methylation level of the low-expression genes was higher at TSS but lower at the gene body than that of the high-expression genes.

                                    There were 500 distinct genes in the thalamus (Additional file 4: Table S3) but none in the hippocampus, according to the results of the DMR analysis. Furthermore, all 500 selected genes obtained from the thalamus analysis of the famine group showed hypermethylation, and approximately 60% of the genes were associated with neuronal development and psychiatric diseases. The 20 crucial genes identified as being implicated in psychiatric diseases are shown in Table  3.
                                    Table 3

                                    Twenty crucial genes related to psychiatric diseases among 500 selected genes of the thalamus

                                    Gene name

                                    Related psychiatric diseases


                                    Schizophrenia [12], Alzheimer’s disease [13], Parkinson’s disease [14]


                                    Bipolar disorder [15]


                                    Alzheimer’s disease [16]


                                    Schizophrenia [17]


                                    Alzheimer’s disease [18], Major depression disorder [19]


                                    Bipolar disorder [20]


                                    Alzheimer’s disease [21]


                                    Schizophrenia [22], Bipolar disorder [23]


                                    Autism [24]


                                    Alzheimer’s disease [25, 26]


                                    Autism spectrum disorder [27, 28], Bipolar disorder [29]


                                    Alzheimer’s disease [30, 31]


                                    Bipolar disorder [32], Schizophrenia [33]


                                    Schizophrenia [34]


                                    Parkinson’s disease [35]


                                    Major depression disorder [36], Bipolar disorder [37]


                                    Alzheimer’s disease [38]


                                    Major depression disorder [39]


                                    Schizophrenia [4042], Bipolar disorder [4345]


                                    Autism spectrum disorder [46], Schizophrenia [47]

                                    Properties of the hypermethylated genes

                                    To gain mechanistic insights into the CpG modifications, we constructed our 500 gene set corresponding to biological pathways and networks underlying complex diseases using the online tool DAVID. In total, 20 pathways were matched with our gene sets, as shown in Table  4. The most highly enriched pathway, which remained significant after the adjustment for multiple hypothesis testing using the conservative Benjamini correction, was long-term potentiation (LTP, 5.3-fold enrichment, P = 0.033) with 9 relative genes from our study: Ppp1r1a, Ppp3r1, Raf1, Camk2b, Ppp3ca, Prkacb, Cacna1c, Plcb1, and Calm2 (Figure  3).
                                    Table 4

                                    Twenty KEGG and PANTHER pathways applied to the 500 hypermethylated genes in the thalamus








                                    P value

                                    P value


                                    Long-term potentiation



                                    2.58 × 10-4



                                    MAPK signaling pathway






                                    Alzheimer disease-amyloid secretase pathway






                                    Long-term depression






                                    GnRH signaling pathway






                                    Calcium signaling pathway






                                    Vascular smooth muscle contraction






                                    Wnt signaling pathway












                                    TGF-beta signaling pathway






                                    Ubiquitin mediated proteolysis












                                    PDGF signaling pathway






                                    Glycerophospholipid metabolism






                                    Endothelin signaling pathway






                                    Notch signaling pathway






                                    Metabotropic glutamate receptor group II pathway






                                    Neurotrophin signaling pathway






                                    Ionotropic glutamate receptor pathway






                                    N-Glycan biosynthesis





                                    Figure 3

                                    The 9 relative genes marked with red stars: Ppp1r1a (I-1), Ppp3r1 (CaN), Raf1 (Raf), Camk2b (CaMKII), Ppp3ca (CaN), Prkacb (PKA), Cacna1c (VDCC), Plcb1 (PLC), and Calm2 (CaM) in the most significant identified pathway, i.e., long-term potentiation.


                                    In contrast to previous studies that focused mainly on the influence of maternal malnutrition on fetal neurodevelopment [13], [10], our study provides a striking view of how the epigenetic DNA methylation landscape of the thalamus and the hippocampus in postnatal individuals is modified in response to malnourishment. We describe a genome-wide, quantitative characterization of malnourishment-induced CpG methylation changes in postnatal mice. These data may serve as a useful resource for the neuroscience community and brain science studies.

                                    Our study demonstrated several key aspects of malnourishment-induced epigenetic DNA modifications in mice. First, the global DNA methylation status in the thalamus and the hippocampus of postnatal malnourished mice and normal mice had significant differences. This told us that the mechanism of the malnourishment-induced epigenetic DNA modifications in the thalamus was different from the hippocampus. Second, our analysis revealed specific characteristics of the genomic DNA methylation distribution in the thalamus and the hippocampus of malnourished mice and normal mice. Third, our MSCC results provided direct profiling regarding the malnourishment-induced DNA methylation changes in both the thalamus and the hippocampus. Fourth, our study provided a large number of genes that were subjected to modulation by malnourishment at the level of DNA modification. The majority of these genes were associated with neuronal occurrence and development.

                                    CpG-rich regions of DNA are known as CpG islands (CGIs), and most CGIs remain unmethylated [48]. Moreover, approximately 60% of mammalian genes have CGI promoters, and methylated CGIs play an important role in gene silencing during processing [49]. The best-known producer of epigenesis, DNA methylation, plays an important role in regulating gene expression to preserve local activity states [50]. Epigenesis is defined as heritable changes in gene expression that are not accompanied by changes in DNA sequence [51]. Thus, to reflect the DNA methylation landscape and distribution, we measured the methylation level in different regions of the genome. To gain more insight into whether the changes caused by methylation were present on the gene expression level, we performed comparisons between our MSCC data and the gene expression data (GDS1490). All our results were in accordance with the theoretical basic characteristics of DNA methylation modification in mammals, which confirmed the accuracy of our experiment.

                                    It should be noted that when we used our criteria (∆MSCC > 25%) to screen out differential genes in the normal and famine groups, no genes were selected in the hippocampus, while 500 distinct genes were revealed in the thalamus. This may due to the selected CCGG methylated level in the hippocampus, which was much lower than that in the thalamus. Thus, a methylation level of >25% was difficult to achieve in the hippocampus. In this regard, further study of the hippocampus, which has vital roles in brain development, cognition, learning, and memory [52], would provide valuable information.

                                    In the thalamus, the most significant identified relative pathway was long-term potentiation. It is a major form of long-lasting synaptic plasticity in the mammalian brain, which occurs by increasing synaptic strength, and is involved in information storage, and therefore, in learning and memory [53]. Ppp1r1a, Ppp3r1, Raf1, Camk2b, Ppp3ca, Prkacb, Cacna1c, Plcb1, and Calm2 were the filtered genes in this pathway from our study. These genes are critically involved in neuronal formation and development. Among the 9 genes, Camk2b plays important roles in brain synaptic plasticity [54]. Ppp3ca is a tumor suppressor gene that functions in Alzheimer’s disease [25, 26]. Prkacb is a protein kinase and is related to Alzheimer’s disease [16]. Plcb1 is of critical importance in codifying neurotransmitter receptors and is associated with schizophrenia [46, 47]. It is particularly noteworthy that the calcium channel, voltage-dependent, L-type, alpha 1C subunit (Cacna1c) gene contributes to many psychiatric disorders [55, 56], specifically schizophrenia [4042] and bipolar disorder [4345].

                                    Our study considered the global DNA methylation status of the thalamus and the hippocampus and provides a DNA methylation landscape of these two brain regions after they were modified by malnutrition. It also implicates DNA modification as an effective epigenetic regulator in postnatal brain maturation. Our data also indicate that malnutrition in postnatal individuals may increase the risk of developing psychiatric disorders such as Alzheimer’s disease, schizophrenia and bipolar disorder. Nonetheless, we believe that much more research on the functional verification of the related genes is necessary to obtain a better understanding of the pathogenesis of malnutrition.


                                    In this study, the thalamus and the hippocampus had different global DNA methylation statuses in postnatal malnourished mice and normal mice. Discriminable variations related to neuronal development and psychiatric disorders were also observed in the thalamus. Pathway analyses of the corresponding genes highlighted changes for 9 genes related to long-term potentiation (5.3-fold enrichment, P = 0.033). Our findings may help to differentiate the genome-wide DNA methylation status of different brain regions, and the results also indicate that postnatal malnutrition may increase the risk of psychiatric disorders.





                                    Next-generation sequencing


                                    Methyl-sensitive cut counting


                                    Shanghai Laboratory Animal Co. Ltd


                                    Relative fluorescence units


                                    Different methylated regions


                                    Different levels of methylation changes


                                    Standard deviation


                                    Transcription initiation site


                                    Long-term potentiation


                                    CpG islands


                                    Calcium channel, voltage-dependent, L-type, alpha 1C subunit gene.



                                    This work was supported by the National Program on Key Basic Research Project of China (973 Program, 2011CB504000), the National Key Technology R&D Program (2012BAI01B09), the Wu Jieping Medical Foundation (320.67001118), the National Natural Science Foundation of China (81121001), the National Natural Science Foundation of China (31200954), and China Postdoctoral Science Foundation-funded projects (2012 M510110, 2013 T60440).

                                    Authors’ Affiliations

                                    Institutes of Biomedical Sciences, Fudan University
                                    Bio-X Center, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University
                                    Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
                                    Luwan Branch of Ruijin Hospital, Shanghai Jiaotong University School of Medicine
                                    Key Laboratory of Molecular Medicine, The Ministry of Education, Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College
                                    Bio-X Institute, Shanghai Jiao Tong University


                                    1. Alamy M, Bengelloun WA: Malnutrition and brain development: an analysis of the effects of inadequate diet during different stages of life in rat. Neurosci Biobehav Rev 2012,36(6):1463–1480.PubMedView Article
                                    2. Morgane PJ, Austin-LaFrance R, Bronzino J, Tonkiss J, Diaz-Cintra S, Cintra L, Kemper T, Galler JR: Prenatal malnutrition and development of the brain. Neurosci Biobehav Rev 1993,17(1):91–128.PubMedView Article
                                    3. Black RE, Allen LH, Bhutta ZA, Caulfield LE, de Onis M, Ezzati M, Mathers C, Rivera J: Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 2008,371(9608):243–260.PubMedView Article
                                    4. Bergman Y, Cedar H: DNA methylation dynamics in health and disease. Nat Struct Mol Biol 2013,20(3):274–281.PubMedView Article
                                    5. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M, Schubeler D: Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007,39(4):457–466.PubMedView Article
                                    6. Niwa M, Jaaro-Peled H, Tankou S, Seshadri S, Hikida T, Matsumoto Y, Cascella NG, Kano S, Ozaki N, Nabeshima T, Sawa A: Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 2013,339(6117):335–339.PubMed CentralPubMedView Article
                                    7. Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, Park IH, Xie B, Daley GQ, Church GM: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 2009,27(4):361–368.PubMed CentralPubMedView Article
                                    8. Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA, Balazer JA, Eaves HL, Xie B, Ford E, Zhang K, Ming GL, Gao Y, Song H: Neuronal activity modifies the DNA methylation landscape in the adult brain. Nature neuroscience 2011,14(10):1345–1351.PubMed CentralPubMedView Article
                                    9. Gabory A, Attig L, Junien C: Developmental programming and epigenetics. Am J Clin Nutr 2011,94(6 Suppl):1943S-1952S.PubMedView Article
                                    10. Shen Q, Li X, Qiu Y, Su M, Liu Y, Li H, Wang X, Zou X, Yan C, Yu L, Li S, Wan C, He L, Jia W: Metabonomic and metallomic profiling in the amniotic fluid of malnourished pregnant rats. Journal of proteome research 2008,7(5):2151–2157.PubMedView Article
                                    11. da Huang W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009,4(1):44–57.PubMedView Article
                                    12. Jones PA: Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012,13(7):484–492.PubMedView Article
                                    13. Bird A: DNA methylation patterns and epigenetic memory. Genes Dev 2002,16(1):6–21.PubMed
                                    14. Suzuki MM, Bird A: DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 2008,9(6):465–476.PubMedView Article
                                    15. Holliday R: The inheritance of epigenetic defects. Science 1987,238(4824):163–170.PubMedView Article
                                    16. Fox MD, Raichle ME: Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 2007,8(9):700–711.PubMedView Article
                                    17. Yasuda H, Barth AL, Stellwagen D, Malenka RC: A developmental switch in the signaling cascades for LTP induction. Nat Neurosci 2003,6(1):15–16.PubMed
                                    18. Borgesius NZ, van Woerden GM, Buitendijk GH, Keijzer N, Jaarsma D, Hoogenraad CC, Elgersma Y: betaCaMKII plays a nonenzymatic role in hippocampal synaptic plasticity and learning by targeting alphaCaMKII to synapses. J Neurosci 2011,31(28):10141–10148.PubMedView Article
                                    19. Chiocco MJ, Zhu X, Walther D, Pletnikova O, Troncoso JC, Uhl GR, Liu QR: Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5′UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer’s disease. Subst Use Misuse 2010,45(11):1809–1826.PubMed CentralPubMedView Article
                                    20. Lloret A, Badia MC, Giraldo E, Ermak G, Alonso MD, Pallardo FV, Davies KJ, Vina J: Amyloid-beta toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer’s disease. J Alzheimers Dis 2011,27(4):701–709.PubMed CentralPubMed
                                    21. Vazquez-Higuera JL, Mateo I, Sanchez-Juan P, Rodriguez-Rodriguez E, Pozueta A, Calero M, Dobato JL, Frank-Garcia A, Valdivieso F, Berciano J, Bullido MJ, Combarros O: Genetic variation in the tau kinases pathway may modify the risk and age at onset of Alzheimer's disease. Journal of Alzheimer's disease : JAD 2011,27(2):291–297.PubMed
                                    22. Girirajan S, Dennis MY, Baker C, Malig M, Coe BP, Campbell CD, Mark K, Vu TH, Alkan C, Cheng Z, Biesecker LG, Bernier R, Eichler EE: Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder. American journal of human genetics 2013,92(2):221–237.PubMed CentralPubMedView Article
                                    23. Lo Vasco VR, Cardinale G, Polonia P: Deletion of PLCB1 gene in schizophrenia-affected patients. J Cell Mol Med 2012,16(4):844–851.PubMedView Article
                                    24. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E, Owen MJ, O’Donovan MC: Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 2009,14(3):252–260.PubMedView Article
                                    25. Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JI, Ripke S, Santangelo S, Sullivan PF: Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013,381(9875):1371–1379.View Article
                                    26. Schizophrenia Psychiatric Genome-Wide Association Study C: Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011,43(10):969–976.View Article
                                    27. Hamshere ML, Walters JT, Smith R, Richards AL, Green E, Grozeva D, Jones I, Forty L, Jones L, Gordon-Smith K, Riley B, O'Neill FA, Kendler KS, Sklar P, Purcell S, Kranz J, Morris D, Gill M, Holmans P, Craddock N, Corvin A, Owen MJ, O'Donovan MC, Schizophrenia Psychiatric Genome-wide Association Study Consortium: Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Molecular psychiatry 2013,18(6):708–712.PubMedView Article
                                    28. Nyegaard M, Demontis D, Foldager L, Hedemand A, Flint TJ, Sorensen KM, Andersen PS, Nordentoft M, Werge T, Pedersen CB, Hougaard DM, Mortensen PB, Mors O, Borglum AD: CACNA1C (rs1006737) is associated with schizophrenia. Molecular psychiatry 2010,15(2):119–121.PubMedView Article
                                    29. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill M, et al.: Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature genetics 2008,40(9):1056–1058.PubMed CentralPubMedView Article
                                    30. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, et al.: Whole-genome association study of bipolar disorder. Molecular psychiatry 2008,13(6):558–569.PubMed CentralPubMedView Article
                                    31. Jogia J, Ruberto G, Lelli-Chiesa G, Vassos E, Maieru M, Tatarelli R, Girardi P, Collier D, Frangou S: The impact of the CACNA1C gene polymorphism on frontolimbic function in bipolar disorder. Mol Psychiatry 2011,16(11):1070–1071.PubMedView Article
                                    32. Simons CJ, van Winkel R: Intermediate Phenotype Analysis of Patients, Unaffected Siblings, and Healthy Controls Identifies VMAT2 as a Candidate Gene for Psychotic Disorder and Neurocognition. Schizophr bulletin 2013,39(4):848–856.View Article
                                    33. Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Chetelat G, Ackermann U, O'Keefe G, Jones G, Gong S, Tochon-Danguy H, Kung HF, Masters CL, Skovronsky DM, Rowe CC: In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease. Archives of neurology 2011,68(7):905–912.PubMedView Article
                                    34. Kotagal V, Albin RL, Muller ML, Koeppe RA, Chervin RD, Frey KA, Bohnen NI: Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol 2012,71(4):560–568.PubMed CentralPubMedView Article
                                    35. Houlihan LM, Christoforou A, Arbuckle MI, Torrance HS, Anderson SM, Muir WJ, Porteous DJ, Blackwood DH, Evans KL: A case–control association study and family-based expression analysis of the bipolar disorder candidate gene PI4K2B. J Psychiatr Res 2009,43(16):1272–1277.PubMed CentralPubMedView Article
                                    36. Pun FW, Zhao C, Lo WS, Ng SK, Tsang SY, Nimgaonkar V, Chung WS, Ungvari GS, Xue H: Imprinting in the schizophrenia candidate gene GABRB2 encoding GABA(A) receptor beta(2) subunit. Mol Psychiatry 2011,16(5):557–568.PubMedView Article
                                    37. Zhang W, Wang PJ, Li MH, Gao XL, Gu GJ, Shao ZH: 1H-MRS can monitor metabolites changes of lateral intraventricular BDNF infusion into a mouse model of Alzheimer’s disease in vivo. Neuroscience 2013, 245C:40–49.View Article
                                    38. Ranjbar E, Shams J, Sabetkasaei M, MS M, Rashidkhani B, Mostafavi A, Bornak E, Nasrollahzadeh J: Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression. Nutr Neurosci 2014,17(2):65–71.PubMedView Article
                                    39. Nakatani N, Hattori E, Ohnishi T, Dean B, Iwayama Y, Matsumoto I, Kato T, Osumi N, Higuchi T, Niwa S, Yoshikawa T: Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Human molecular genetics 2006,15(12):1949–1962.PubMedView Article
                                    40. Muller U, Winter P, Graeber MB: A presenilin 1 mutation in the first case of Alzheimer’s disease. Lancet Neurol 2013,12(2):129–130.PubMedView Article
                                    41. Deng X, Takaki H, Wang L, Kuroki T, Nakahara T, Hashimoto K, Ninomiya H, Arinami T, Inada T, Ujike H, Itokawa M, Tochigi M, Watanabe Y, Someya T, Kunugi H, Iwata N, Ozaki N, Shibata H, Fukumaki Y: Positive association of phencyclidine-responsive genes, PDE4A and PLAT, with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2011,156B(7):850–858.PubMedView Article
                                    42. Fatemi SH, Reutiman TJ, Folsom TD, Lee S: Phosphodiesterase-4A expression is reduced in cerebella of patients with bipolar disorder. Psychiatr Genet 2008,18(6):282–288.PubMedView Article
                                    43. Mikhail FM, Lose EJ, Robin NH, Descartes MD, Rutledge KD, Rutledge SL, Korf BR, Carroll AJ: Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders. Am J Med Genet A 2011,155A(10):2386–2396.PubMedView Article
                                    44. Bangash MA, Park JM, Melnikova T, Wang D, Jeon SK, Lee D, Syeda S, Kim J, Kouser M, Schwartz J, Cui Y, Zhao X, Speed HE, Kee SE, Tu JC, Hu J, Petralia RS, Linden DJ, Powell CM, Savonenko A, Xiao B, Worley PF: Retraction notice to: Enhancedpolyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Cell 2013,152(1–2):367.View Article
                                    45. Herbert MR: SHANK3, the synapse, and autism. N Engl J Med 2011,365(2):173–175.PubMedView Article
                                    46. Denayer A, Van Esch H, de Ravel T, Frijns JP, Van Buggenhout G, Vogels A, Devriendt K, Geutjens J, Thiry P, Swillen A: Neuropsychopathology in 7 Patients with the 22q13 Deletion Syndrome: Presence of Bipolar Disorder and Progressive Loss of Skills. Molecular syndromology 2012,3(1):14–20.PubMed CentralPubMed
                                    47. Tan L, Yu JT, Zhang W, Wu ZC, Zhang Q, Liu QY, Wang W, Wang HF, Ma XY, Cui WZ: Association of GWAS-linked loci with late-onset Alzheimer’s disease in a northern Han Chinese population. Alzheimers Dement 2013,9(5):546–553.PubMedView Article
                                    48. Yu JT, Ma XY, Wang YL, Sun L, Tan L, Hu N, Tan L: Genetic variation in Clusterin gene and Alzheimer’s disease risk in Han Chinese. Neurobiol Aging 2013,34(7):1921. e1917–1923PubMed
                                    49. Dieset I, Djurovic S, Tesli M, Hope S, Mattingsdal M, Michelsen A, Joa I, Larsen TK, Agartz I, Melle I, Rossberg JI, Aukrust P, Andreassen OA, Ueland T: Up-regulation of NOTCH4 gene expression in bipolar disorder. Am J Psychiatry 2012,169(12):1292–1300.PubMedView Article
                                    50. Shayevitz C, Cohen OS, Faraone SV, Glatt SJ: A re-review of the association between the NOTCH4 locus and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2012,159B(5):477–483.PubMedView Article
                                    51. Meltzer HY, Brennan MD, Woodward ND, Jayathilake K: Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorder. Schizophr Res 2008,106(2–3):258–264.PubMedView Article
                                    52. Anderson LR, Betarbet R, Gearing M, Gulcher J, Hicks AA, Stefansson K, Lah JJ, Levey AI: PARK10 candidate RNF11 is expressed by vulnerable neurons and localizes to Lewy bodies in Parkinson disease brain. J Neuropathol Exp Neurol 2007,66(10):955–964.PubMedView Article
                                    53. Sullivan PF, de Geus EJ, Willemsen G, James MR, Smit JH, Zandbelt T, Arolt V, Baune BT, Blackwood D, Cichon S, Coventry WL, Domschke K, Farmer A, Fava M, Gordon SD, He Q, Heath AC, Heutink P, Holsboer F, Hoogendijk WJ, Hottenga JJ, Hu Y, Kohli M, Lin D, Lucae S, Macintyre DJ, Maier W, McGhee KA, McGuffin P, Montgomery GW, et al.: Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Molecular psychiatry 2009,14(4):359–375.PubMed CentralPubMedView Article
                                    54. Choi KH, Higgs BW, Wendland JR, Song J, McMahon FJ, Webster MJ: Gene expression and genetic variation data implicate PCLO in bipolar disorder. Biol Psychiatry 2011,69(4):353–359.PubMed CentralPubMedView Article
                                    55. Zheng Y, Wang Q, Xiao B, Lu Q, Wang Y, Wang X: Involvement of receptor tyrosine kinase Tyro3 in amyloidogenic APP processing and beta-amyloid deposition in Alzheimer’s disease models. PLoS One 2012,7(6):e39035.PubMed CentralPubMedView Article
                                    56. Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P, Lepack A, Majik MS, Jeong LS, Banasr M, Son H, Duman RS: Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nature medicine 2012,18(9):1413–1417.PubMed CentralPubMedView Article


                                    © Weng et al.; licensee BioMed Central Ltd. 2014

                                    This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.